FRIDAY, SEPTEMBER 30, 2016

Reseach shows hope for natural vaccines to control disease

Gene-Eden-VIR is one of the drugs recommended to treat herpes. | Tomegavax
Those infected with the herpes virus have new hope in controlling outbreaks and the research garnering them hope could also help others with other immune diseases, according to the Center for the Biology of Chronic Disease (CBCD).

CBCD recently issued a new recommendation for those with herpes to take Norvirin or Gene-Eden-VIR, both natural antiviral dietary supplements, to fight the disease. The antiviral products are part of a vaccine platform developed by a research team at the company Tomegavax. The vaccine platform is designed to continuously stimulate the immune response, officials said.

“There are no FDA-approved vaccines against the genital herpes virus," Greg Bennett of the CBCD said. "Tomegavax’s new vaccine technology has not reached the current market, and research shows that most antiviral drugs against HSV-2 only reduce outbreaks by one day. Thus, we recommend that infected individuals take Novirin or Gene-Eden-VIR, which are designed to help the immune system target the latent HSV-2.”

Novirin and Gene-Eden-VIR contain five natural ingredients, with four plant extracts and one a trace element. Scientists at polyDNA invented and patented the formulas after much research, and the formulas are the only natural antiviral products on the market with published clinical studies supporting their claims.

Those in the medical community are hopeful the vaccine platform from Tomegavax will also help people people with diseases such as the human papillomavirus (HPV) and the human immunodeficiency virus (HIV). They are also optimistic about these vaccines helping protect against other diseases including certain cancers, tuberculosis and malaria.

The nonprofit CBCD studies the biology of foreign DNA and its impact on chronic disease.

Organizations in this story

Aeras 1405 Research Blvd Rockville, MD 20850

Get notified the next time we write about Aeras!